Prediction of the efficacy of first transarterial chemoembolization for advanced hepatocellular carcinoma via a clinical-radiomics model

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 23

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

HTML

248

Figures (1-6)

137

Tables (1-7)

130

Sum=543

Publishing Process of This Article

Item

Count

Browse

Download

Sum=96

Aug 16, 2025 (publication date) through Jun 28, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Trials Study

World J Clin Cases. Aug 16, 2025; 13(23): 101742
Published online Aug 16, 2025. doi: 10.12998/wjcc.v13.i23.101742

Table 5 Results of the multifactorial logistic regression analysis of the efficacy of transarterial chemoembolization treatment

OR: Odds ratio; PT: Prothrombin time; AFP: Alpha-fetoprotein.

Citation: Zhao KF, Xie CB, Wu Y. Prediction of the efficacy of first transarterial chemoembolization for advanced hepatocellular carcinoma via a clinical-radiomics model. World J Clin Cases 2025; 13(23): 101742
URL: https://www.wjgnet.com/2307-8960/full/v13/i23/101742.htm
DOI: https://dx.doi.org/10.12998/wjcc.v13.i23.101742